Skip to search formSkip to main contentSkip to account menu

pirogliride

Known as: 1-pyrrolidinecarboximidamide, N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-, N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboxamidine 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (2)

McN 3495pirogliride tartrate

Broader (1)

Pyrrolidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Metabolic fate of the hypoglycemic agent pirogliride in laboratory animals and humans.
1989
1989
Postreceptor Regulation of Insulin Action in Primary Cultures of Rat Hepatocytes by Oral Hypoglycemic Agents: Effects of Linogliride and Chlorpropamide
We have previously demonstrated the ability of the sulfonylurea tolazamide to potentiate insulin action in primary cultures of… 
1986
1986
Pharmacologic profile and insulin secretagogue effect of linogliride (McN‐3935), a new, orally effective hypoglycemic agent
Linogliride (McN‐3935) [N‐(1‐methyl‐2‐pyrrolidinylidene)‐N'‐phenyl‐4‐morpholinecarboximidamide] was selected for clinical… 
1983
1983
Effect of the oral hypoglycemic agent pirogliride (McN-3495) on glycogen levels of normal and diabetic rats.
Pirogliride, a new oral hypoglycemic agent unrelated structurally or mechanistically to either the sulfonylureas or biguanides… 
1980
1980
Pirogliride: An Oral Hypoglycemic Drug Which Accelerates Glucose Usage and Insulin Secretion by Islets of Langerhans
Pirogiiride potentiates glucose-induced insulin secretion from isolated islets. This effect is accompanied by a facilitated… 
1980
1980
Effect of the oral hypoglycemic agent, pirogliride, on gluconeogenesis.
1979
1979
Effect of the oral hypoglycemic agent, pirogliride, on lipolysis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)